Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) just unveiled an update.
WuXi AppTec Co., Ltd. has completed its first share repurchase plan for 2025, buying back 11,860,809 A Shares, which represents 0.40% of its total issued share capital. The repurchase, which utilized approximately RMB1 billion, will not materially impact the company’s operations or financial standing and ensures compliance with listing requirements.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$137.10 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. operates in the pharmaceutical and biotechnology industry, providing comprehensive research and development services. The company focuses on drug discovery, development, and manufacturing services, catering to a global market.
Average Trading Volume: 8,878,349
Technical Sentiment Signal: Buy
Current Market Cap: HK$305.2B
See more data about 2359 stock on TipRanks’ Stock Analysis page.